Odonate Therapeutics™
Get Full AccessDescription
- Odonate Therapeutics is dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Our initial focus is on the development of tesetaxel, a novel, orally administered taxane. We are initiating a multinational, multicenter, Phase 3 study in locally advanced or metastatic breast cancer (MBC). Our goal is to develop an effective chemotherapy choice for patients that provides quality-of-life advantages over current alternatives.
-
Headquarters:4747 Executive Dr Ste 510 , San Diego, California, United States
More -
Phone Number: +1 858-731-8180
-
Website: https://www.odonate.com
-
Employees:124
-
Revenue:$100 - 250M
-
Legal Name:Odonate Therapeutics™
-
Odonate Therapeutics™'s Social Media
-
Is this data correct?
-
| NAICS Code: 541714 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Odonate Therapeutics™
-
Where are Odonate Therapeutics™'s Headquarters?
Odonate Therapeutics™'s Headquarters are in 4747 Executive Dr Ste 510 ,San Diego,California,United States
-
What is Odonate Therapeutics™'s phone number?
Odonate Therapeutics™'s phone number is +1 858-731-8180
-
What is Odonate Therapeutics™'s official website?
Odonate Therapeutics™'s official website is https://www.odonate.com
-
What is Odonate Therapeutics™'s Revenue?
Odonate Therapeutics™'s revenue is $100 - 250M
-
What is Odonate Therapeutics™'s NAICS code?
Odonate Therapeutics™'s NAICS code is 541714
-
How many employees are working in Odonate Therapeutics™
Odonate Therapeutics™ has 124 employees
-
What is Odonate Therapeutics™'s Industry?
Odonate Therapeutics™ is in the industry of Biotechnology
-
Who is Odonate Therapeutics™'s Board Member?
Odonate Therapeutics™'s Board Member is Robert Rosen